Canadian Securities Regulators' Review Finds Medical Marijuana Business Disclosure Deficient

TORONTO, Feb. 23, 2015 /CNW/ - Members of the Canadian Securities Administrators (CSA) today released CSA Staff Notice 51-342 Staff Review of Issuers Entering Into Medical Marijuana Business Opportunities, which summarizes the CSA's findings and disclosure expectations for reporting issuers contemplating involvement in Canada's medical marijuana industry. The CSA's review aimed to determine if ...



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1AnSv9i

via IFTTT